Form D · Biotechnology
Mist Inhalation Wellness Technology Ltd
Grand Cayman, E9 · CIK 0002047967
Offering snapshot reported Dec 10, 2024 · SEC filing
- Reported sold
- Yet to sell Offering amount: $40M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 10, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Debt, Other
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-531558
Shares (NASDAQ-Approving Stock Listing Code: "WXKJ").
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Manhattan Securities Group | None |
Source: Form D, filed Dec 10, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bin Wu Zhuang | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4 Th Floor, Harbour Place, 103 South Church Street, P.O. Box 10240
Grand Cayman, E9, KY1-1002
Grand Cayman, E9, KY1-1002